Add another Item to this comparison
Add Item
Basic Information |
Generic Name |
|
Dextroamphetamine |
vs |
Methylphenidate |
|
Class |
|
Cns Stimulants |
vs |
Cns Stimulants |
|
Prescription Generic Available |
|
Yes |
vs |
Yes |
|
Pregnancy cat. |
|
B3(au) C(us) |
vs |
C(us) |
|
Approved Age |
|
6 And Older |
vs |
6 And Older |
|
Legal Status |
|
Controlled (s8)(au)
Schedule I(ca) Class B(uk) Schedule Ii(us) |
vs |
Schedule Ii (us) |
|
WADA Category |
|
|
vs |
S6 - Stimulants |
|
Dependence Liability |
|
High |
vs |
Moderate |
|
Excretion |
|
Urinary |
vs |
Urinary |
|
Possible Side Effects |
|
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
vs |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
Dosage, Usage and Forms |
Routes (of administration) |
|
Oral, Insufflation, Rectal, Sublingual |
vs |
Oral |
|
Dosage |
|
|
vs |
10 Mg Q Am–30 Bid (max
60mg/day) |
|
Maximum daily dose |
|
|
vs |
60 mg |
|
Duration |
|
Short-acting |
vs |
Intermediate-acting |
|
Duration - time |
|
4-6 H |
vs |
6-8 H |
|
Chemical Data |
Molecular mass (g/mol) |
|
135.21 G/mol |
vs |
269.77 G/mol |
|
Half Life |
|
4-6 Hrs |
vs |
3.4 Hours |
|
Formula |
|
C9h13n |
vs |
C14h19no2•hcl |
|
Bioavailability |
|
75% (oral) |
vs |
30 % |
|
Protein binding |
|
15 % |
vs |
15 % |
|
Metabolism |
|
Hepatic |
vs |
Hepatic |
|
Compare Dexedrine vs Metadate ER ADHD Medications
cancel